Global Epilepsy Devices Market by Prediction Devices (Electroencephalogram (Electroencephalogram EEG), by End User (Neurology Centers, Hospitals), by Surface Electromyography (sEMG), by Product Type (Implantable Devices, Wearable Devices, Conventional Devices), by Electrocardiography (EKG), by Technology (Vagus Nerve Stimulation (Vagus Nerve Stimulation VNS), by Electrodermal Activity (EDA) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Epilepsy Devices Market research report which is segmented by Prediction Devices (Electroencephalogram (Electroencephalogram EEG), by End User (Neurology Centers, Hospitals), by Surface Electromyography (sEMG), by Product Type (Implantable Devices, Wearable Devices, Conventional Devices), by Electrocardiography (EKG), by Technology (Vagus Nerve Stimulation (Vagus Nerve Stimulation VNS), by Electrodermal Activity (EDA), By Players/Companies Empatica Inc., MC10, Medpage Ltd., Medtronic Plc. , Compumedics Ltd., St. Jude Medical Inc., Koninklijke Philips N.V., Natus Medical Incorporated, Neuropace Inc., Boston Scientific Corporation, Cerbomed GmbH, Nihon Kohden Corporation, Liva Nova”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Epilepsy Devices Market Research Report |
| By Prediction Devices (Electroencephalogram | Electroencephalogram EEG |
| By End User | Neurology Centers, Hospitals |
| By Surface Electromyography | sEMG |
| By Product Type | Implantable Devices, Wearable Devices, Conventional Devices |
| By Electrocardiography | EKG |
| By Technology (Vagus Nerve Stimulation | Vagus Nerve Stimulation VNS |
| By Electrodermal Activity | EDA |
| By Companies | Empatica Inc., MC10, Medpage Ltd., Medtronic Plc. , Compumedics Ltd., St. Jude Medical Inc., Koninklijke Philips N.V., Natus Medical Incorporated, Neuropace Inc., Boston Scientific Corporation, Cerbomed GmbH, Nihon Kohden Corporation, Liva Nova |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 227 |
| Number of Tables & Figures | 159 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Epilepsy Devices Market Report Segments:
The market is segmented by Prediction Devices (Electroencephalogram (Electroencephalogram EEG), by End User (Neurology Centers, Hospitals), by Surface Electromyography (sEMG), by Product Type (Implantable Devices, Wearable Devices, Conventional Devices), by Electrocardiography (EKG), by Technology (Vagus Nerve Stimulation (Vagus Nerve Stimulation VNS), by Electrodermal Activity (EDA).
Epilepsy Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Epilepsy Devices Market
Overview of the regional outlook of the Epilepsy Devices Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Epilepsy Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Epilepsy Devices Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Electroencephalogram EEG
7. By End User:1. Neurology Centers
2. Hospitals
8. By Surface Electromyography:1. sEMG
9. By Product Type:1. Implantable Devices
2. Wearable Devices
3. Conventional Devices
10. By Electrocardiography:1. EKG
11. By Technology (Vagus Nerve Stimulation:1. Vagus Nerve Stimulation VNS
12. By Electrodermal Activity:1. EDA
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Epilepsy Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Epilepsy Devices Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Epilepsy Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Epilepsy Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Epilepsy Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Epilepsy Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Epilepsy Devices Market Size & Forecast, 2018-2028
4.5.1 Epilepsy Devices Market Size and Y-o-Y Growth
4.5.2 Epilepsy Devices Market Absolute $ Opportunity
Chapter 5 Global Epilepsy Devices Market Analysis and Forecast by Prediction Devices (Electroencephalogram
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Prediction Devices (Electroencephalogram
5.1.2 Basis Point Share (BPS) Analysis by Prediction Devices (Electroencephalogram
5.1.3 Absolute $ Opportunity Assessment by Prediction Devices (Electroencephalogram
5.2 Epilepsy Devices Market Size Forecast by Prediction Devices (Electroencephalogram
5.2.1 Electroencephalogram EEG
5.3 Market Attractiveness Analysis by Prediction Devices (Electroencephalogram
Chapter 6 Global Epilepsy Devices Market Analysis and Forecast by End User
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by End User
6.1.2 Basis Point Share (BPS) Analysis by End User
6.1.3 Absolute $ Opportunity Assessment by End User
6.2 Epilepsy Devices Market Size Forecast by End User
6.2.1 Neurology Centers
6.2.2 Hospitals
6.3 Market Attractiveness Analysis by End User
Chapter 7 Global Epilepsy Devices Market Analysis and Forecast by Surface Electromyography
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Surface Electromyography
7.1.2 Basis Point Share (BPS) Analysis by Surface Electromyography
7.1.3 Absolute $ Opportunity Assessment by Surface Electromyography
7.2 Epilepsy Devices Market Size Forecast by Surface Electromyography
7.2.1 sEMG
7.3 Market Attractiveness Analysis by Surface Electromyography
Chapter 8 Global Epilepsy Devices Market Analysis and Forecast by Product Type
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Product Type
8.1.2 Basis Point Share (BPS) Analysis by Product Type
8.1.3 Absolute $ Opportunity Assessment by Product Type
8.2 Epilepsy Devices Market Size Forecast by Product Type
8.2.1 Implantable Devices
8.2.2 Wearable Devices
8.2.3 Conventional Devices
8.3 Market Attractiveness Analysis by Product Type
Chapter 9 Global Epilepsy Devices Market Analysis and Forecast by Electrocardiography
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Electrocardiography
9.1.2 Basis Point Share (BPS) Analysis by Electrocardiography
9.1.3 Absolute $ Opportunity Assessment by Electrocardiography
9.2 Epilepsy Devices Market Size Forecast by Electrocardiography
9.2.1 EKG
9.3 Market Attractiveness Analysis by Electrocardiography
Chapter 10 Global Epilepsy Devices Market Analysis and Forecast by Technology (Vagus Nerve Stimulation
10.1 Introduction
10.1.1 Key Market Trends & Growth Opportunities by Technology (Vagus Nerve Stimulation
10.1.2 Basis Point Share (BPS) Analysis by Technology (Vagus Nerve Stimulation
10.1.3 Absolute $ Opportunity Assessment by Technology (Vagus Nerve Stimulation
10.2 Epilepsy Devices Market Size Forecast by Technology (Vagus Nerve Stimulation
10.2.1 Vagus Nerve Stimulation VNS
10.3 Market Attractiveness Analysis by Technology (Vagus Nerve Stimulation
Chapter 11 Global Epilepsy Devices Market Analysis and Forecast by Electrodermal Activity
11.1 Introduction
11.1.1 Key Market Trends & Growth Opportunities by Electrodermal Activity
11.1.2 Basis Point Share (BPS) Analysis by Electrodermal Activity
11.1.3 Absolute $ Opportunity Assessment by Electrodermal Activity
11.2 Epilepsy Devices Market Size Forecast by Electrodermal Activity
11.2.1 EDA
11.3 Market Attractiveness Analysis by Electrodermal Activity
Chapter 12 Global Epilepsy Devices Market Analysis and Forecast by Region
12.1 Introduction
12.1.1 Key Market Trends & Growth Opportunities by Region
12.1.2 Basis Point Share (BPS) Analysis by Region
12.1.3 Absolute $ Opportunity Assessment by Region
12.2 Epilepsy Devices Market Size Forecast by Region
12.2.1 North America
12.2.2 Europe
12.2.3 Asia Pacific
12.2.4 Latin America
12.2.5 Middle East & Africa (MEA)
12.3 Market Attractiveness Analysis by Region
Chapter 13 Coronavirus Disease (COVID-19) Impact
13.1 Introduction
13.2 Current & Future Impact Analysis
13.3 Economic Impact Analysis
13.4 Government Policies
13.5 Investment Scenario
Chapter 14 North America Epilepsy Devices Analysis and Forecast
14.1 Introduction
14.2 North America Epilepsy Devices Market Size Forecast by Country
14.2.1 U.S.
14.2.2 Canada
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 North America Epilepsy Devices Market Size Forecast by Prediction Devices (Electroencephalogram
14.6.1 Electroencephalogram EEG
14.7 Basis Point Share (BPS) Analysis by Prediction Devices (Electroencephalogram
14.8 Absolute $ Opportunity Assessment by Prediction Devices (Electroencephalogram
14.9 Market Attractiveness Analysis by Prediction Devices (Electroencephalogram
14.10 North America Epilepsy Devices Market Size Forecast by End User
14.10.1 Neurology Centers
14.10.2 Hospitals
14.11 Basis Point Share (BPS) Analysis by End User
14.12 Absolute $ Opportunity Assessment by End User
14.13 Market Attractiveness Analysis by End User
14.14 North America Epilepsy Devices Market Size Forecast by Surface Electromyography
14.14.1 sEMG
14.15 Basis Point Share (BPS) Analysis by Surface Electromyography
14.16 Absolute $ Opportunity Assessment by Surface Electromyography
14.17 Market Attractiveness Analysis by Surface Electromyography
14.18 North America Epilepsy Devices Market Size Forecast by Product Type
14.18.1 Implantable Devices
14.18.2 Wearable Devices
14.18.3 Conventional Devices
14.19 Basis Point Share (BPS) Analysis by Product Type
14.20 Absolute $ Opportunity Assessment by Product Type
14.21 Market Attractiveness Analysis by Product Type
14.22 North America Epilepsy Devices Market Size Forecast by Electrocardiography
14.22.1 EKG
14.23 Basis Point Share (BPS) Analysis by Electrocardiography
14.24 Absolute $ Opportunity Assessment by Electrocardiography
14.25 Market Attractiveness Analysis by Electrocardiography
14.26 North America Epilepsy Devices Market Size Forecast by Technology (Vagus Nerve Stimulation
14.26.1 Vagus Nerve Stimulation VNS
14.27 Basis Point Share (BPS) Analysis by Technology (Vagus Nerve Stimulation
14.28 Absolute $ Opportunity Assessment by Technology (Vagus Nerve Stimulation
14.29 Market Attractiveness Analysis by Technology (Vagus Nerve Stimulation
14.30 North America Epilepsy Devices Market Size Forecast by Electrodermal Activity
14.30.1 EDA
14.31 Basis Point Share (BPS) Analysis by Electrodermal Activity
14.32 Absolute $ Opportunity Assessment by Electrodermal Activity
14.33 Market Attractiveness Analysis by Electrodermal Activity
Chapter 15 Europe Epilepsy Devices Analysis and Forecast
15.1 Introduction
15.2 Europe Epilepsy Devices Market Size Forecast by Country
15.2.1 Germany
15.2.2 France
15.2.3 Italy
15.2.4 U.K.
15.2.5 Spain
15.2.6 Russia
15.2.7 Rest of Europe
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Europe Epilepsy Devices Market Size Forecast by Prediction Devices (Electroencephalogram
15.6.1 Electroencephalogram EEG
15.7 Basis Point Share (BPS) Analysis by Prediction Devices (Electroencephalogram
15.8 Absolute $ Opportunity Assessment by Prediction Devices (Electroencephalogram
15.9 Market Attractiveness Analysis by Prediction Devices (Electroencephalogram
15.10 Europe Epilepsy Devices Market Size Forecast by End User
15.10.1 Neurology Centers
15.10.2 Hospitals
15.11 Basis Point Share (BPS) Analysis by End User
15.12 Absolute $ Opportunity Assessment by End User
15.13 Market Attractiveness Analysis by End User
15.14 Europe Epilepsy Devices Market Size Forecast by Surface Electromyography
15.14.1 sEMG
15.15 Basis Point Share (BPS) Analysis by Surface Electromyography
15.16 Absolute $ Opportunity Assessment by Surface Electromyography
15.17 Market Attractiveness Analysis by Surface Electromyography
15.18 Europe Epilepsy Devices Market Size Forecast by Product Type
15.18.1 Implantable Devices
15.18.2 Wearable Devices
15.18.3 Conventional Devices
15.19 Basis Point Share (BPS) Analysis by Product Type
15.20 Absolute $ Opportunity Assessment by Product Type
15.21 Market Attractiveness Analysis by Product Type
15.22 Europe Epilepsy Devices Market Size Forecast by Electrocardiography
15.22.1 EKG
15.23 Basis Point Share (BPS) Analysis by Electrocardiography
15.24 Absolute $ Opportunity Assessment by Electrocardiography
15.25 Market Attractiveness Analysis by Electrocardiography
15.26 Europe Epilepsy Devices Market Size Forecast by Technology (Vagus Nerve Stimulation
15.26.1 Vagus Nerve Stimulation VNS
15.27 Basis Point Share (BPS) Analysis by Technology (Vagus Nerve Stimulation
15.28 Absolute $ Opportunity Assessment by Technology (Vagus Nerve Stimulation
15.29 Market Attractiveness Analysis by Technology (Vagus Nerve Stimulation
15.30 Europe Epilepsy Devices Market Size Forecast by Electrodermal Activity
15.30.1 EDA
15.31 Basis Point Share (BPS) Analysis by Electrodermal Activity
15.32 Absolute $ Opportunity Assessment by Electrodermal Activity
15.33 Market Attractiveness Analysis by Electrodermal Activity
Chapter 16 Asia Pacific Epilepsy Devices Analysis and Forecast
16.1 Introduction
16.2 Asia Pacific Epilepsy Devices Market Size Forecast by Country
16.2.1 China
16.2.2 Japan
16.2.3 South Korea
16.2.4 India
16.2.5 Australia
16.2.6 South East Asia (SEA)
16.2.7 Rest of Asia Pacific (APAC)
16.3 Basis Point Share (BPS) Analysis by Country
16.4 Absolute $ Opportunity Assessment by Country
16.5 Market Attractiveness Analysis by Country
16.6 Asia Pacific Epilepsy Devices Market Size Forecast by Prediction Devices (Electroencephalogram
16.6.1 Electroencephalogram EEG
16.7 Basis Point Share (BPS) Analysis by Prediction Devices (Electroencephalogram
16.8 Absolute $ Opportunity Assessment by Prediction Devices (Electroencephalogram
16.9 Market Attractiveness Analysis by Prediction Devices (Electroencephalogram
16.10 Asia Pacific Epilepsy Devices Market Size Forecast by End User
16.10.1 Neurology Centers
16.10.2 Hospitals
16.11 Basis Point Share (BPS) Analysis by End User
16.12 Absolute $ Opportunity Assessment by End User
16.13 Market Attractiveness Analysis by End User
16.14 Asia Pacific Epilepsy Devices Market Size Forecast by Surface Electromyography
16.14.1 sEMG
16.15 Basis Point Share (BPS) Analysis by Surface Electromyography
16.16 Absolute $ Opportunity Assessment by Surface Electromyography
16.17 Market Attractiveness Analysis by Surface Electromyography
16.18 Asia Pacific Epilepsy Devices Market Size Forecast by Product Type
16.18.1 Implantable Devices
16.18.2 Wearable Devices
16.18.3 Conventional Devices
16.19 Basis Point Share (BPS) Analysis by Product Type
16.20 Absolute $ Opportunity Assessment by Product Type
16.21 Market Attractiveness Analysis by Product Type
16.22 Asia Pacific Epilepsy Devices Market Size Forecast by Electrocardiography
16.22.1 EKG
16.23 Basis Point Share (BPS) Analysis by Electrocardiography
16.24 Absolute $ Opportunity Assessment by Electrocardiography
16.25 Market Attractiveness Analysis by Electrocardiography
16.26 Asia Pacific Epilepsy Devices Market Size Forecast by Technology (Vagus Nerve Stimulation
16.26.1 Vagus Nerve Stimulation VNS
16.27 Basis Point Share (BPS) Analysis by Technology (Vagus Nerve Stimulation
16.28 Absolute $ Opportunity Assessment by Technology (Vagus Nerve Stimulation
16.29 Market Attractiveness Analysis by Technology (Vagus Nerve Stimulation
16.30 Asia Pacific Epilepsy Devices Market Size Forecast by Electrodermal Activity
16.30.1 EDA
16.31 Basis Point Share (BPS) Analysis by Electrodermal Activity
16.32 Absolute $ Opportunity Assessment by Electrodermal Activity
16.33 Market Attractiveness Analysis by Electrodermal Activity
Chapter 17 Latin America Epilepsy Devices Analysis and Forecast
17.1 Introduction
17.2 Latin America Epilepsy Devices Market Size Forecast by Country
17.2.1 Brazil
17.2.2 Mexico
17.2.3 Rest of Latin America (LATAM)
17.3 Basis Point Share (BPS) Analysis by Country
17.4 Absolute $ Opportunity Assessment by Country
17.5 Market Attractiveness Analysis by Country
17.6 Latin America Epilepsy Devices Market Size Forecast by Prediction Devices (Electroencephalogram
17.6.1 Electroencephalogram EEG
17.7 Basis Point Share (BPS) Analysis by Prediction Devices (Electroencephalogram
17.8 Absolute $ Opportunity Assessment by Prediction Devices (Electroencephalogram
17.9 Market Attractiveness Analysis by Prediction Devices (Electroencephalogram
17.10 Latin America Epilepsy Devices Market Size Forecast by End User
17.10.1 Neurology Centers
17.10.2 Hospitals
17.11 Basis Point Share (BPS) Analysis by End User
17.12 Absolute $ Opportunity Assessment by End User
17.13 Market Attractiveness Analysis by End User
17.14 Latin America Epilepsy Devices Market Size Forecast by Surface Electromyography
17.14.1 sEMG
17.15 Basis Point Share (BPS) Analysis by Surface Electromyography
17.16 Absolute $ Opportunity Assessment by Surface Electromyography
17.17 Market Attractiveness Analysis by Surface Electromyography
17.18 Latin America Epilepsy Devices Market Size Forecast by Product Type
17.18.1 Implantable Devices
17.18.2 Wearable Devices
17.18.3 Conventional Devices
17.19 Basis Point Share (BPS) Analysis by Product Type
17.20 Absolute $ Opportunity Assessment by Product Type
17.21 Market Attractiveness Analysis by Product Type
17.22 Latin America Epilepsy Devices Market Size Forecast by Electrocardiography
17.22.1 EKG
17.23 Basis Point Share (BPS) Analysis by Electrocardiography
17.24 Absolute $ Opportunity Assessment by Electrocardiography
17.25 Market Attractiveness Analysis by Electrocardiography
17.26 Latin America Epilepsy Devices Market Size Forecast by Technology (Vagus Nerve Stimulation
17.26.1 Vagus Nerve Stimulation VNS
17.27 Basis Point Share (BPS) Analysis by Technology (Vagus Nerve Stimulation
17.28 Absolute $ Opportunity Assessment by Technology (Vagus Nerve Stimulation
17.29 Market Attractiveness Analysis by Technology (Vagus Nerve Stimulation
17.30 Latin America Epilepsy Devices Market Size Forecast by Electrodermal Activity
17.30.1 EDA
17.31 Basis Point Share (BPS) Analysis by Electrodermal Activity
17.32 Absolute $ Opportunity Assessment by Electrodermal Activity
17.33 Market Attractiveness Analysis by Electrodermal Activity
Chapter 18 Middle East & Africa (MEA) Epilepsy Devices Analysis and Forecast
18.1 Introduction
18.2 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by Country
18.2.1 Saudi Arabia
18.2.2 South Africa
18.2.3 UAE
18.2.4 Rest of Middle East & Africa (MEA)
18.3 Basis Point Share (BPS) Analysis by Country
18.4 Absolute $ Opportunity Assessment by Country
18.5 Market Attractiveness Analysis by Country
18.6 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by Prediction Devices (Electroencephalogram
18.6.1 Electroencephalogram EEG
18.7 Basis Point Share (BPS) Analysis by Prediction Devices (Electroencephalogram
18.8 Absolute $ Opportunity Assessment by Prediction Devices (Electroencephalogram
18.9 Market Attractiveness Analysis by Prediction Devices (Electroencephalogram
18.10 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by End User
18.10.1 Neurology Centers
18.10.2 Hospitals
18.11 Basis Point Share (BPS) Analysis by End User
18.12 Absolute $ Opportunity Assessment by End User
18.13 Market Attractiveness Analysis by End User
18.14 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by Surface Electromyography
18.14.1 sEMG
18.15 Basis Point Share (BPS) Analysis by Surface Electromyography
18.16 Absolute $ Opportunity Assessment by Surface Electromyography
18.17 Market Attractiveness Analysis by Surface Electromyography
18.18 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by Product Type
18.18.1 Implantable Devices
18.18.2 Wearable Devices
18.18.3 Conventional Devices
18.19 Basis Point Share (BPS) Analysis by Product Type
18.20 Absolute $ Opportunity Assessment by Product Type
18.21 Market Attractiveness Analysis by Product Type
18.22 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by Electrocardiography
18.22.1 EKG
18.23 Basis Point Share (BPS) Analysis by Electrocardiography
18.24 Absolute $ Opportunity Assessment by Electrocardiography
18.25 Market Attractiveness Analysis by Electrocardiography
18.26 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by Technology (Vagus Nerve Stimulation
18.26.1 Vagus Nerve Stimulation VNS
18.27 Basis Point Share (BPS) Analysis by Technology (Vagus Nerve Stimulation
18.28 Absolute $ Opportunity Assessment by Technology (Vagus Nerve Stimulation
18.29 Market Attractiveness Analysis by Technology (Vagus Nerve Stimulation
18.30 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by Electrodermal Activity
18.30.1 EDA
18.31 Basis Point Share (BPS) Analysis by Electrodermal Activity
18.32 Absolute $ Opportunity Assessment by Electrodermal Activity
18.33 Market Attractiveness Analysis by Electrodermal Activity
Chapter 19 Competition Landscape
19.1 Epilepsy Devices Market: Competitive Dashboard
19.2 Global Epilepsy Devices Market: Market Share Analysis, 2019
19.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
19.3.1 Empatica Inc.
19.3.2 MC10
19.3.3 Medpage Ltd.
19.3.4 Medtronic Plc.
19.3.5 Compumedics Ltd.
19.3.6 St. Jude Medical Inc.
19.3.7 Koninklijke Philips N.V.
19.3.8 Natus Medical Incorporated
19.3.9 Neuropace Inc.
19.3.10 Boston Scientific Corporation
19.3.11 Cerbomed GmbH
19.3.12 Nihon Kohden Corporation
19.3.13 Liva Nova
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Epilepsy Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Epilepsy Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Epilepsy Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Epilepsy Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Epilepsy Devices Market Size & Forecast, 2018-2028
4.5.1 Epilepsy Devices Market Size and Y-o-Y Growth
4.5.2 Epilepsy Devices Market Absolute $ Opportunity
Chapter 5 Global Epilepsy Devices Market Analysis and Forecast by Prediction Devices (Electroencephalogram
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Prediction Devices (Electroencephalogram
5.1.2 Basis Point Share (BPS) Analysis by Prediction Devices (Electroencephalogram
5.1.3 Absolute $ Opportunity Assessment by Prediction Devices (Electroencephalogram
5.2 Epilepsy Devices Market Size Forecast by Prediction Devices (Electroencephalogram
5.2.1 Electroencephalogram EEG
5.3 Market Attractiveness Analysis by Prediction Devices (Electroencephalogram
Chapter 6 Global Epilepsy Devices Market Analysis and Forecast by End User
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by End User
6.1.2 Basis Point Share (BPS) Analysis by End User
6.1.3 Absolute $ Opportunity Assessment by End User
6.2 Epilepsy Devices Market Size Forecast by End User
6.2.1 Neurology Centers
6.2.2 Hospitals
6.3 Market Attractiveness Analysis by End User
Chapter 7 Global Epilepsy Devices Market Analysis and Forecast by Surface Electromyography
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Surface Electromyography
7.1.2 Basis Point Share (BPS) Analysis by Surface Electromyography
7.1.3 Absolute $ Opportunity Assessment by Surface Electromyography
7.2 Epilepsy Devices Market Size Forecast by Surface Electromyography
7.2.1 sEMG
7.3 Market Attractiveness Analysis by Surface Electromyography
Chapter 8 Global Epilepsy Devices Market Analysis and Forecast by Product Type
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Product Type
8.1.2 Basis Point Share (BPS) Analysis by Product Type
8.1.3 Absolute $ Opportunity Assessment by Product Type
8.2 Epilepsy Devices Market Size Forecast by Product Type
8.2.1 Implantable Devices
8.2.2 Wearable Devices
8.2.3 Conventional Devices
8.3 Market Attractiveness Analysis by Product Type
Chapter 9 Global Epilepsy Devices Market Analysis and Forecast by Electrocardiography
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Electrocardiography
9.1.2 Basis Point Share (BPS) Analysis by Electrocardiography
9.1.3 Absolute $ Opportunity Assessment by Electrocardiography
9.2 Epilepsy Devices Market Size Forecast by Electrocardiography
9.2.1 EKG
9.3 Market Attractiveness Analysis by Electrocardiography
Chapter 10 Global Epilepsy Devices Market Analysis and Forecast by Technology (Vagus Nerve Stimulation
10.1 Introduction
10.1.1 Key Market Trends & Growth Opportunities by Technology (Vagus Nerve Stimulation
10.1.2 Basis Point Share (BPS) Analysis by Technology (Vagus Nerve Stimulation
10.1.3 Absolute $ Opportunity Assessment by Technology (Vagus Nerve Stimulation
10.2 Epilepsy Devices Market Size Forecast by Technology (Vagus Nerve Stimulation
10.2.1 Vagus Nerve Stimulation VNS
10.3 Market Attractiveness Analysis by Technology (Vagus Nerve Stimulation
Chapter 11 Global Epilepsy Devices Market Analysis and Forecast by Electrodermal Activity
11.1 Introduction
11.1.1 Key Market Trends & Growth Opportunities by Electrodermal Activity
11.1.2 Basis Point Share (BPS) Analysis by Electrodermal Activity
11.1.3 Absolute $ Opportunity Assessment by Electrodermal Activity
11.2 Epilepsy Devices Market Size Forecast by Electrodermal Activity
11.2.1 EDA
11.3 Market Attractiveness Analysis by Electrodermal Activity
Chapter 12 Global Epilepsy Devices Market Analysis and Forecast by Region
12.1 Introduction
12.1.1 Key Market Trends & Growth Opportunities by Region
12.1.2 Basis Point Share (BPS) Analysis by Region
12.1.3 Absolute $ Opportunity Assessment by Region
12.2 Epilepsy Devices Market Size Forecast by Region
12.2.1 North America
12.2.2 Europe
12.2.3 Asia Pacific
12.2.4 Latin America
12.2.5 Middle East & Africa (MEA)
12.3 Market Attractiveness Analysis by Region
Chapter 13 Coronavirus Disease (COVID-19) Impact
13.1 Introduction
13.2 Current & Future Impact Analysis
13.3 Economic Impact Analysis
13.4 Government Policies
13.5 Investment Scenario
Chapter 14 North America Epilepsy Devices Analysis and Forecast
14.1 Introduction
14.2 North America Epilepsy Devices Market Size Forecast by Country
14.2.1 U.S.
14.2.2 Canada
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 North America Epilepsy Devices Market Size Forecast by Prediction Devices (Electroencephalogram
14.6.1 Electroencephalogram EEG
14.7 Basis Point Share (BPS) Analysis by Prediction Devices (Electroencephalogram
14.8 Absolute $ Opportunity Assessment by Prediction Devices (Electroencephalogram
14.9 Market Attractiveness Analysis by Prediction Devices (Electroencephalogram
14.10 North America Epilepsy Devices Market Size Forecast by End User
14.10.1 Neurology Centers
14.10.2 Hospitals
14.11 Basis Point Share (BPS) Analysis by End User
14.12 Absolute $ Opportunity Assessment by End User
14.13 Market Attractiveness Analysis by End User
14.14 North America Epilepsy Devices Market Size Forecast by Surface Electromyography
14.14.1 sEMG
14.15 Basis Point Share (BPS) Analysis by Surface Electromyography
14.16 Absolute $ Opportunity Assessment by Surface Electromyography
14.17 Market Attractiveness Analysis by Surface Electromyography
14.18 North America Epilepsy Devices Market Size Forecast by Product Type
14.18.1 Implantable Devices
14.18.2 Wearable Devices
14.18.3 Conventional Devices
14.19 Basis Point Share (BPS) Analysis by Product Type
14.20 Absolute $ Opportunity Assessment by Product Type
14.21 Market Attractiveness Analysis by Product Type
14.22 North America Epilepsy Devices Market Size Forecast by Electrocardiography
14.22.1 EKG
14.23 Basis Point Share (BPS) Analysis by Electrocardiography
14.24 Absolute $ Opportunity Assessment by Electrocardiography
14.25 Market Attractiveness Analysis by Electrocardiography
14.26 North America Epilepsy Devices Market Size Forecast by Technology (Vagus Nerve Stimulation
14.26.1 Vagus Nerve Stimulation VNS
14.27 Basis Point Share (BPS) Analysis by Technology (Vagus Nerve Stimulation
14.28 Absolute $ Opportunity Assessment by Technology (Vagus Nerve Stimulation
14.29 Market Attractiveness Analysis by Technology (Vagus Nerve Stimulation
14.30 North America Epilepsy Devices Market Size Forecast by Electrodermal Activity
14.30.1 EDA
14.31 Basis Point Share (BPS) Analysis by Electrodermal Activity
14.32 Absolute $ Opportunity Assessment by Electrodermal Activity
14.33 Market Attractiveness Analysis by Electrodermal Activity
Chapter 15 Europe Epilepsy Devices Analysis and Forecast
15.1 Introduction
15.2 Europe Epilepsy Devices Market Size Forecast by Country
15.2.1 Germany
15.2.2 France
15.2.3 Italy
15.2.4 U.K.
15.2.5 Spain
15.2.6 Russia
15.2.7 Rest of Europe
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Europe Epilepsy Devices Market Size Forecast by Prediction Devices (Electroencephalogram
15.6.1 Electroencephalogram EEG
15.7 Basis Point Share (BPS) Analysis by Prediction Devices (Electroencephalogram
15.8 Absolute $ Opportunity Assessment by Prediction Devices (Electroencephalogram
15.9 Market Attractiveness Analysis by Prediction Devices (Electroencephalogram
15.10 Europe Epilepsy Devices Market Size Forecast by End User
15.10.1 Neurology Centers
15.10.2 Hospitals
15.11 Basis Point Share (BPS) Analysis by End User
15.12 Absolute $ Opportunity Assessment by End User
15.13 Market Attractiveness Analysis by End User
15.14 Europe Epilepsy Devices Market Size Forecast by Surface Electromyography
15.14.1 sEMG
15.15 Basis Point Share (BPS) Analysis by Surface Electromyography
15.16 Absolute $ Opportunity Assessment by Surface Electromyography
15.17 Market Attractiveness Analysis by Surface Electromyography
15.18 Europe Epilepsy Devices Market Size Forecast by Product Type
15.18.1 Implantable Devices
15.18.2 Wearable Devices
15.18.3 Conventional Devices
15.19 Basis Point Share (BPS) Analysis by Product Type
15.20 Absolute $ Opportunity Assessment by Product Type
15.21 Market Attractiveness Analysis by Product Type
15.22 Europe Epilepsy Devices Market Size Forecast by Electrocardiography
15.22.1 EKG
15.23 Basis Point Share (BPS) Analysis by Electrocardiography
15.24 Absolute $ Opportunity Assessment by Electrocardiography
15.25 Market Attractiveness Analysis by Electrocardiography
15.26 Europe Epilepsy Devices Market Size Forecast by Technology (Vagus Nerve Stimulation
15.26.1 Vagus Nerve Stimulation VNS
15.27 Basis Point Share (BPS) Analysis by Technology (Vagus Nerve Stimulation
15.28 Absolute $ Opportunity Assessment by Technology (Vagus Nerve Stimulation
15.29 Market Attractiveness Analysis by Technology (Vagus Nerve Stimulation
15.30 Europe Epilepsy Devices Market Size Forecast by Electrodermal Activity
15.30.1 EDA
15.31 Basis Point Share (BPS) Analysis by Electrodermal Activity
15.32 Absolute $ Opportunity Assessment by Electrodermal Activity
15.33 Market Attractiveness Analysis by Electrodermal Activity
Chapter 16 Asia Pacific Epilepsy Devices Analysis and Forecast
16.1 Introduction
16.2 Asia Pacific Epilepsy Devices Market Size Forecast by Country
16.2.1 China
16.2.2 Japan
16.2.3 South Korea
16.2.4 India
16.2.5 Australia
16.2.6 South East Asia (SEA)
16.2.7 Rest of Asia Pacific (APAC)
16.3 Basis Point Share (BPS) Analysis by Country
16.4 Absolute $ Opportunity Assessment by Country
16.5 Market Attractiveness Analysis by Country
16.6 Asia Pacific Epilepsy Devices Market Size Forecast by Prediction Devices (Electroencephalogram
16.6.1 Electroencephalogram EEG
16.7 Basis Point Share (BPS) Analysis by Prediction Devices (Electroencephalogram
16.8 Absolute $ Opportunity Assessment by Prediction Devices (Electroencephalogram
16.9 Market Attractiveness Analysis by Prediction Devices (Electroencephalogram
16.10 Asia Pacific Epilepsy Devices Market Size Forecast by End User
16.10.1 Neurology Centers
16.10.2 Hospitals
16.11 Basis Point Share (BPS) Analysis by End User
16.12 Absolute $ Opportunity Assessment by End User
16.13 Market Attractiveness Analysis by End User
16.14 Asia Pacific Epilepsy Devices Market Size Forecast by Surface Electromyography
16.14.1 sEMG
16.15 Basis Point Share (BPS) Analysis by Surface Electromyography
16.16 Absolute $ Opportunity Assessment by Surface Electromyography
16.17 Market Attractiveness Analysis by Surface Electromyography
16.18 Asia Pacific Epilepsy Devices Market Size Forecast by Product Type
16.18.1 Implantable Devices
16.18.2 Wearable Devices
16.18.3 Conventional Devices
16.19 Basis Point Share (BPS) Analysis by Product Type
16.20 Absolute $ Opportunity Assessment by Product Type
16.21 Market Attractiveness Analysis by Product Type
16.22 Asia Pacific Epilepsy Devices Market Size Forecast by Electrocardiography
16.22.1 EKG
16.23 Basis Point Share (BPS) Analysis by Electrocardiography
16.24 Absolute $ Opportunity Assessment by Electrocardiography
16.25 Market Attractiveness Analysis by Electrocardiography
16.26 Asia Pacific Epilepsy Devices Market Size Forecast by Technology (Vagus Nerve Stimulation
16.26.1 Vagus Nerve Stimulation VNS
16.27 Basis Point Share (BPS) Analysis by Technology (Vagus Nerve Stimulation
16.28 Absolute $ Opportunity Assessment by Technology (Vagus Nerve Stimulation
16.29 Market Attractiveness Analysis by Technology (Vagus Nerve Stimulation
16.30 Asia Pacific Epilepsy Devices Market Size Forecast by Electrodermal Activity
16.30.1 EDA
16.31 Basis Point Share (BPS) Analysis by Electrodermal Activity
16.32 Absolute $ Opportunity Assessment by Electrodermal Activity
16.33 Market Attractiveness Analysis by Electrodermal Activity
Chapter 17 Latin America Epilepsy Devices Analysis and Forecast
17.1 Introduction
17.2 Latin America Epilepsy Devices Market Size Forecast by Country
17.2.1 Brazil
17.2.2 Mexico
17.2.3 Rest of Latin America (LATAM)
17.3 Basis Point Share (BPS) Analysis by Country
17.4 Absolute $ Opportunity Assessment by Country
17.5 Market Attractiveness Analysis by Country
17.6 Latin America Epilepsy Devices Market Size Forecast by Prediction Devices (Electroencephalogram
17.6.1 Electroencephalogram EEG
17.7 Basis Point Share (BPS) Analysis by Prediction Devices (Electroencephalogram
17.8 Absolute $ Opportunity Assessment by Prediction Devices (Electroencephalogram
17.9 Market Attractiveness Analysis by Prediction Devices (Electroencephalogram
17.10 Latin America Epilepsy Devices Market Size Forecast by End User
17.10.1 Neurology Centers
17.10.2 Hospitals
17.11 Basis Point Share (BPS) Analysis by End User
17.12 Absolute $ Opportunity Assessment by End User
17.13 Market Attractiveness Analysis by End User
17.14 Latin America Epilepsy Devices Market Size Forecast by Surface Electromyography
17.14.1 sEMG
17.15 Basis Point Share (BPS) Analysis by Surface Electromyography
17.16 Absolute $ Opportunity Assessment by Surface Electromyography
17.17 Market Attractiveness Analysis by Surface Electromyography
17.18 Latin America Epilepsy Devices Market Size Forecast by Product Type
17.18.1 Implantable Devices
17.18.2 Wearable Devices
17.18.3 Conventional Devices
17.19 Basis Point Share (BPS) Analysis by Product Type
17.20 Absolute $ Opportunity Assessment by Product Type
17.21 Market Attractiveness Analysis by Product Type
17.22 Latin America Epilepsy Devices Market Size Forecast by Electrocardiography
17.22.1 EKG
17.23 Basis Point Share (BPS) Analysis by Electrocardiography
17.24 Absolute $ Opportunity Assessment by Electrocardiography
17.25 Market Attractiveness Analysis by Electrocardiography
17.26 Latin America Epilepsy Devices Market Size Forecast by Technology (Vagus Nerve Stimulation
17.26.1 Vagus Nerve Stimulation VNS
17.27 Basis Point Share (BPS) Analysis by Technology (Vagus Nerve Stimulation
17.28 Absolute $ Opportunity Assessment by Technology (Vagus Nerve Stimulation
17.29 Market Attractiveness Analysis by Technology (Vagus Nerve Stimulation
17.30 Latin America Epilepsy Devices Market Size Forecast by Electrodermal Activity
17.30.1 EDA
17.31 Basis Point Share (BPS) Analysis by Electrodermal Activity
17.32 Absolute $ Opportunity Assessment by Electrodermal Activity
17.33 Market Attractiveness Analysis by Electrodermal Activity
Chapter 18 Middle East & Africa (MEA) Epilepsy Devices Analysis and Forecast
18.1 Introduction
18.2 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by Country
18.2.1 Saudi Arabia
18.2.2 South Africa
18.2.3 UAE
18.2.4 Rest of Middle East & Africa (MEA)
18.3 Basis Point Share (BPS) Analysis by Country
18.4 Absolute $ Opportunity Assessment by Country
18.5 Market Attractiveness Analysis by Country
18.6 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by Prediction Devices (Electroencephalogram
18.6.1 Electroencephalogram EEG
18.7 Basis Point Share (BPS) Analysis by Prediction Devices (Electroencephalogram
18.8 Absolute $ Opportunity Assessment by Prediction Devices (Electroencephalogram
18.9 Market Attractiveness Analysis by Prediction Devices (Electroencephalogram
18.10 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by End User
18.10.1 Neurology Centers
18.10.2 Hospitals
18.11 Basis Point Share (BPS) Analysis by End User
18.12 Absolute $ Opportunity Assessment by End User
18.13 Market Attractiveness Analysis by End User
18.14 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by Surface Electromyography
18.14.1 sEMG
18.15 Basis Point Share (BPS) Analysis by Surface Electromyography
18.16 Absolute $ Opportunity Assessment by Surface Electromyography
18.17 Market Attractiveness Analysis by Surface Electromyography
18.18 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by Product Type
18.18.1 Implantable Devices
18.18.2 Wearable Devices
18.18.3 Conventional Devices
18.19 Basis Point Share (BPS) Analysis by Product Type
18.20 Absolute $ Opportunity Assessment by Product Type
18.21 Market Attractiveness Analysis by Product Type
18.22 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by Electrocardiography
18.22.1 EKG
18.23 Basis Point Share (BPS) Analysis by Electrocardiography
18.24 Absolute $ Opportunity Assessment by Electrocardiography
18.25 Market Attractiveness Analysis by Electrocardiography
18.26 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by Technology (Vagus Nerve Stimulation
18.26.1 Vagus Nerve Stimulation VNS
18.27 Basis Point Share (BPS) Analysis by Technology (Vagus Nerve Stimulation
18.28 Absolute $ Opportunity Assessment by Technology (Vagus Nerve Stimulation
18.29 Market Attractiveness Analysis by Technology (Vagus Nerve Stimulation
18.30 Middle East & Africa (MEA) Epilepsy Devices Market Size Forecast by Electrodermal Activity
18.30.1 EDA
18.31 Basis Point Share (BPS) Analysis by Electrodermal Activity
18.32 Absolute $ Opportunity Assessment by Electrodermal Activity
18.33 Market Attractiveness Analysis by Electrodermal Activity
Chapter 19 Competition Landscape
19.1 Epilepsy Devices Market: Competitive Dashboard
19.2 Global Epilepsy Devices Market: Market Share Analysis, 2019
19.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
19.3.1 Empatica Inc.
19.3.2 MC10
19.3.3 Medpage Ltd.
19.3.4 Medtronic Plc.
19.3.5 Compumedics Ltd.
19.3.6 St. Jude Medical Inc.
19.3.7 Koninklijke Philips N.V.
19.3.8 Natus Medical Incorporated
19.3.9 Neuropace Inc.
19.3.10 Boston Scientific Corporation
19.3.11 Cerbomed GmbH
19.3.12 Nihon Kohden Corporation
19.3.13 Liva Nova
Segments Covered in the Report
The global Epilepsy Devices market has been segmented based on
By Prediction Devices (Electroencephalogram
The global Epilepsy Devices market has been segmented based on
By Prediction Devices (Electroencephalogram
- Electroencephalogram EEG
- Neurology Centers
- Hospitals
- sEMG
- Implantable Devices
- Wearable Devices
- Conventional Devices
- EKG
- Vagus Nerve Stimulation VNS
- EDA
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Empatica Inc.
- MC10
- Medpage Ltd.
- Medtronic Plc.
- Compumedics Ltd.
- St. Jude Medical Inc.
- Koninklijke Philips N.V.
- Natus Medical Incorporated
- Neuropace Inc.
- Boston Scientific Corporation
- Cerbomed GmbH
- Nihon Kohden Corporation
- Liva Nova
Our Clients
Related Reports
Some other reports from this category!
